In the news
Oncology Continues to be Top Spend Category in Medical Pharmacy
December 14, 2022Formulary Watch
Related news
In the news
April 19, 2024
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
American Journal of Managed Care (AJMC): Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments
In the news
April 19, 2024
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
American Journal of Managed Care (AJMC): At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes
In the news
April 18, 2024
Dr. YuQian Liu Investigates the Future Benefits of Cell, Gene Therapies Using Real-World Data
American Journal of Managed Care (AJMC): YuQian Liu, PharmD, Magellan Rx Management, explores the current space of cell and gene therapies based on real-world data and potential emerging therapies in the future, while expanding upon long-term efficacy concerns